Oral Vaccines Market Estimated to Flourish by 2017 - 2025 - Persistence Market Research

The Oral Vaccines Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Oral Vaccines Market: Drivers and Challenges

The global market for oral vaccines is primarily driven by increasing prevalence of infectious diseases in developing countries, bioterrorism, resistance to existing vaccines, etc. In addition to this, patient adherence to needle-free vaccine regime, preference to oral vaccines by children and geriatric population, cost effective nature, recent FDA approvals to oral vaccines for diseases such as cholera etc. are some of the factors expected to fuel the growth of global oral vaccines market. However, compromised immunogenicity in children and cost for maintaining a cold chain, inaccessibility in remote areas etc. are some of the factors limiting growth of global oral vaccines market. For instance, maintenance of cold chain for oral vaccines across the globe costs over US$ 300 Mn per year.

Oral Vaccines Market: Key Players

Some of the players operating in global oral vaccines market are GlaxoSmithKline Plc., PaxVax Corporation, Merial, Inc., Merck Sharp & Dohme Corp. (a subsidiary of Merck & Co. Inc.), VALNEVA Canada Inc., QUÍMICA SUIZA S.A., Immunitor, Inc., Aventis (Sanofi S.A.), Serum Institute of India Pvt. Ltd., Swiss Serum and Vaccine Institute Berne, Bull Bio - NCIPD Ltd., Vaxart, Inc., Shantha Biotechnics, Crucell (Janssen Global Services, LLC) and others. Development of oral HIV vaccines is expected to bring a revolutionary change in the infectious disease landscape in some of the African and Latin American countries.

A Sample of this Report is Available Upon Request @ http://www.persistencemarketresearch.com/samples/14395

Oral Vaccines Market: Regional Overview

On the basis of regional presence, global oral vaccines market is segmented into five key regions viz. North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is expected to lead the global market due to existence of highly planned healthcare reimbursement schemes and power of purchasing expensive vaccines In the U.S. Oral vaccines hold special advantage in developing countries where there is a high incidence of infectious diseases and also simple logistics for oral vaccines are highly effective for mass immunization programs.

To View TOC of this Report is Available Upon Request @ http://www.persistencemarketresearch.com/toc/14395

About Us
Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated re-search, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Con-sumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.
PMR stands committed to bringing more accuracy and speed to clients’ business decisions. From ready-to-purchase market research reports to customized research solutions, PMR’s en-gagement models are highly flexible without compromising on its deep-seated research values.

Contact
Persistence Market Research Pvt. Ltd
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
media@persistencemarketresearch.com

This release was published on openPR.